Novartis AG's Fiscal Year is From January To December.
The item "Cash-Ratio" stands at 0.3048 as of 09/30/2025.
As of the end of Novartis AG's third quarter, the item "Cash Ratio" stands at 0.3048. This represents an increase of 38.08 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -38.84 percent compared to the value the year prior.
The 1 year change in percent is -38.84.
The 3 year change in percent is -55.07.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Cash Ratio | 905,699,262,464.00 |
![]() | Johnson & Johnson - Cash Ratio | 486,508,953,600.00 |
![]() | AbbVie Inc - Cash Ratio | 399,570,305,024.00 |
![]() | Roche Holding AG - Cash Ratio | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Cash Ratio | 280,205,508,085.11 |